Aim-To evaluate possible long term side effects of high doses of sex steroids in the management of constitutionally tall stature, with special attention to hypothalamic-gonadal function.
Treatment of tall adolescent boys and girls with high doses of sex steroids in order to reduce their final height is a widespread practice. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] In our hospital we have been treating constitutionally tall children since 1968 . In girls, oestrogens have been used (ethinyloestradiol 200 pLg/day, range: 100-300 mg/day) in combination with progestagens (medroxyprogestrone 5-10 ,ug/ day, orally) every [5] [6] [7] [8] [9] [10] days of the month; boys have been treated with androgens (testosterone esters in various regimens with a total monthly dose of up to 1000 mg.).
Over the years height reduction by means of supraphysiological doses of sex hormones has been much discussed, not only because of the problems in assessing the real growth reducing efficacy and the lowest effective dose, but also because of the possibility of unwanted side effects. In this respect special attention has been focused on haemostasis,'1 lipid metabolism,12 and the function of the hypothalamicgonadal axis.13 14 The impressive bulk of available data on the association between long term oral contraceptive use and possible health risks (reviewed in15 16) are indispensable as they form an excellent reflection of the prospective risks in oestrogen treated girls.
So far, unwanted side effects have only been reported during treatment or shortly after its discontinuation.1-10 [17] [18] [19] [20] [21] Most side effects were found to be mild and reversible.
Suppression of the hypothalamic-gonadal axis induced by the pharmacological doses of sex steroids was found to be reversible.13 14 However, the possibility of a long term suppressive effect of sex hormone treatment on reproductive function in boys has been postulated. 22 In a recent study in 43 previously treated tall men and 30 untreated tall controls we could not confirm this suggestion.23 In girls, the ultimate 'proof of complete reversibility of hypothalamic-gonadal suppression -pregnancy -has been reported in various single cases. 1-4 6 8 9 To offer further data on acceptance and possible long term effects of high doses of sex steroids in the management of constitutionally tall stature we interviewed tall adult men and women at a mean follow up period of 10 years after discontinuation of height reductive therapy by means of a self constructed questionnaire. Our main field of interest was the functioning of the hypothalamic-gonadal axis. Since our study was intended to be noninvasive, this was covered by questions about menstruation, gynaecological complaints and childbearing. Tall adult men and women who had not received treatment during their pubertal period served as controls.
Methods

PATIENTS
Since the introduction ofheight reducing treatment in our institute in 1968, 247 men and 423 women who were seen at adolescence for evaluation of their constitutionally tall stature had reached the age of 18 at the time of our follow up study. All were contacted by mail to (9) 31 (21) 14 (16) Interval bleeding 10 (6) 25 (16) 12 (14) No bleeding 2 (1) 3 (2) 1 (1) 29 We found no important differences in menstrual cycle characteristics between cases and controls. This implies that no important hormonal imbalance is present in previously treated tall women. Malignancy was not reported in our study. The possibility of a dose dependent effect and a relation between either oral contraceptive use at a young age or duration of oral contraceptive use and increased risks of breast cancer30 raises the need for long term follow up in patients treated with pharmacological doses of oestrogens. In our study, only 49 of the 180 cases were older than 30 years at time of the follow up. Therefore, our mean follow up period of almost 11 years in women is still too short to give any answer to this important issue.
In boys, aggravation of acne was by far the most commonly reported side effect. This is in agreement with others.3 5 A causal relationship with androgen treatment is likely, as shown by Fyrand et al. 31 Gynaecomastia occurred in 13% of the cases, probably because of the increased peripheral conversion of androgens to oestrogens. Since gynaecomastia is rather prevalent in population studies in boys,32 it is hard to say whether this condition is increased. In one patient, surgical correction was necessary several years after cessation of treatment .
Thus far, only casuistic data have been available on successful pregnancies after height reducing treatment.l4689 In our follow up study information about a total of 127 pregnancies was obtained and revealed no distinct differences in details and outcome of pregnancies between treated women and men and controls. These results imply that long term effects of high doses of sex hormones on fertility are unlikely. It is tempting to draw definite conclusions at this time, but one should not forget the social trend to have children at a later age and the fact that the control group in men was significantly younger. In addition, the finding in women that a higher proportion of cases (though not significantly so) had sought gynaecological consultation because of subfertility should not be ignored. However, this latter finding is hard to interpret. There is always the possibility of bias by overreporting in cases, as discussed above. Furthermore, additional information about the causes for subfertility in these women showed no clear systematical pattern, indicating that a certain pathophysiological mechanism is unlikely. Finally, the prevalence of infertility in the normal population is of the same order of magnitude (10- In summary, treatment of tall adolescent boys and girls with high doses of sex hormones to reduce their final height was approved by most of the patients, despite the fact that many of them experienced side effects during the treatment. Most side effects were mild. The incidence of side effects is probably dose dependent. Post-treatment amenorrhoea of longer than six months was found in 5% of the women. No important differences in menstrual cycle characteristics were found between cases and controls. Information on a total of 127 pregnancies was obtained and revealed no distinct differences in details and outcome between treated men and women and controls. At a mean follow up period of 10 years, there is no evidence that pharmacological doses of sex hormones have a long term effect on reproductive function or cancer risks. However, this period is still too short to draw definite conclusions. 
